Diligence memo · auto-generated · as of July 2, 2026

Qt Ultrasound Llc

Qt Ultrasound Llc looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Qt Ultrasound Llc operates in Other Health Care, based in NOVATO.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Qt Ultrasound Llc has raised $60M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $70M on 2018-07-01.

Most recent recorded round closed around 2018-05-25.

Valuation (modeled)modeled

Provath models Qt Ultrasound Llc at approximately $572M (range $61M–$2.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.28× the median modeled value of Series B Other Health Care companies in 2016–2018 (74 peers) — value vs value, same stage and era. Within the normal band (128% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 12 months.

Last raise 8.1 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 2.7× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 93% of Other Health Care peers (5377 compared).

Modeled value ranks above 94% of those peers.

Closest niche peers: Podicare Services, Inc., COTA, Inc., Fresenius Medical Care - Meridian Health System, LLC, Headspace, Inc., Spine Holdings LLC.

Peoplefiled

12 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.